Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB-adMSCs for Immune Support Against COVID-19
NCT04349631Phase 2Completed
- Sponsor
- Hope Biosciences
- Start
- Apr 2020
- Primary completion
- Nov 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic HB-adMSCs in coronavirus disease 2019 (COVID-19), sponsored by Hope Biosciences. Started Apr 2020; status: completed.
02
Drugs
allogeneic HB-adMSCs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04349631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349631.